Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 4 Open-market sale President and CEO sold 1,500,000 shares
  2. 8-K Event Material agreement · New debt or obligation · Other events
  3. 10-Q Report Quarterly Report
  4. 10-Q Report Quarterly Report
  5. 10-Q Report Quarterly Report
  6. 10-K Report Annual Report
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13D Stake Beneficial Ownership Report
  12. SC 13G Stake Amended Statement of Ownership
  13. 4 Open-market buy President and CEO bought 22,500 shares at $10.00 ($225,000)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 23 of 24 · 479 filings